Feasibility of home administration of nebulised interferon β-1a (SNG001) for COVID-19: a remote study.

MLA

Francis, Nick A., et al. “Feasibility of Home Administration of Nebulised Interferon β-1a (SNG001) for COVID-19: A Remote Study.” BJGP Open, vol. 7, no. 4, Dec. 2023, pp. 1–9. EBSCOhost, https://doi.org/10.3399/BJGPO.2023.0089.

APA

Francis, N. A., Monk, P. D., Nuttall, J., Oliver, T., Simpson, C., Brookes, J. L., Tear, V. J., Thompson, A. G., Batten, T. N., Mankowski, M., & Wilkinson, T. M. A. (2023). Feasibility of home administration of nebulised interferon β-1a (SNG001) for COVID-19: a remote study. BJGP Open, 7(4), 1–9. https://doi.org/10.3399/BJGPO.2023.0089

Chicago

Francis, Nick A., Phillip D. Monk, Jacqueline Nuttall, Thomas Oliver, Catherine Simpson, Jody L. Brookes, Victoria J. Tear, et al. 2023. “Feasibility of Home Administration of Nebulised Interferon β-1a (SNG001) for COVID-19: A Remote Study.” BJGP Open 7 (4): 1–9. doi:10.3399/BJGPO.2023.0089.